Deal Announcements

Asuragen Receives Venture Capital Financing

Friday, March 22, 2013 5:34:00 AM PDT | VentureDeal

   Austin, Texas  --  Biotechnology company Asuragen has raised $7.5 million in new venture capital equity investment, according to an SEC regulatory filing.

Asuragen is a molecular biology reagent company focused on RNA-based therapeutic diagnostics.

Investors in the round were not disclosed, nor was how the company intends to use the proceeds.

Asuragen is still seeking an additional $7.5 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1